ATS 2019 Virtual Final Program

P865 Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Indigenous/First Nations Communities in Canada: A Random-Sampled Population Study/ P. Camp, K.H. Bartlett, T. Holyk, Vancouver, Canada, p.A4872 P866 Prevalence and Longitudinal Risk Patterns Associated with Preserved Ratio Impaired Spirometry (PRISm): The NHLBI Pooled Cohorts Study/ E.S. Wan, P. Balte, P.A. Cassano, D. Couper, D. Jacobs, R. Kalhan, A. Navas Acien, R.C. Kaplan, J. Sanders, G.T. O’Connor, J.E. Schwartz, S. Yende, M.T. Dransfield, W. White, E.C. Oelsner, Boston, MA, p.A4873 P867 BI 1026706, a Bradykinin 1 Antagonist, Did Not Reduce Pulmonary Inflammation Upon Segmental Endotoxin Challenge in Healthy Current Smoker Subjects Compared with Placebo/ J.M. Hohlfeld, P. Badorrek, C. Faulenbach, K. Hohl, T. Litzenburger, M. Müller, M. Sarno, W. Seibold, A. Gupta, Hannover, Germany, p.A4874 P868 Relationship Between Mortality and Readmission Rate in Hospitalized Patients with Acute Exacerbation of COPD (AECOPD)/ A. Samarghandi, R. Qayyum, Richmond, VA, p.A4875 Facilitator : N. Putcha, MD, Baltimore, MD P869 The Development of Major Cancers in COPD/ J.H. Park, S.S. Sheen, S.V. Ahn, J.H. Jung, P. Hae-Sim, Suwon, Korea, Republic of, p.A4876 P870 Nutritional Assessment of the World Trade Center-Health Program Fire Department of New York Cohort/ R. Lam, J. Riggs, M. Sunseri, S. Kwon, G. Crowley, T. Schwartz, R. Zeig-Owens, A. Halpren, M. Liu, D.J. Prezant, A. Nolan, New York, NY, p.A4877 P871 Case Finding COPD and Comorbid Non-Cystic Fibrosis Bronchiectasis (NCF-BE) in Rural Upstate New York: Keystone to Successful COPD Population Health Management/ F. Seifer, C. Dodd, G. Hansen, D. Weycker, Potsdam, NY, p.A4878 P872 TriOptimize II: The Use of Blood Eosinophil Count in the Care of Patients with COPD Prescribed Single Inhaler Triple Therapy: A Real-World View from Germany/ R. Hoevelmann, S. Bahari Javan, K. Melchior, C.G. Geßner, A. Pfeffermann, Hamburg, Germany, p.A4879 P873 The Characteristics of Smoking History and Outcomes in Post-Mortem Chronic Bronchitis Patients: A Retrospective Study/ L. Zhu, X. Wang, Shanghai, China, p.A4880 P874 Environmental Risk Factors in Malagasy Patients Suffering from Chronic Obstructive Pulmonary Disease/ J. Ratomaharo, M. Randriantahiry, D. Rakotonanahary, R. Rakotoarivelo, M. Randria, L. Razafindrakoto,Athis-Mons, France, p.A4881 P875 Association Between RAGE Gene Polymorphism ( rs1800624, rs2070600 ) with Chronic Obstruction Pulmonary Disease/ H. Niu, T. Yang, T. Yu, R. Duan, Beijing, China, p.A4882 P876 Standardized Discharge Bundle and Associated Impact on 30-Day Readmission Rates and Length of Stay/ C. Atwood, M. Michas, M. Bhutani, L. Deuchar, J. Graham, M. Ospina, B. Rowe, R. Leigh, R. Aceron, R. Damant, P. Faris, N. Hirani, K. Longard, V. Meyer, P. Mitchell, W.H. Tsai, M.K. Stickland, Calgary, Canada, p.A4883 P877 Updated Spirometric Values for Southern Chinese Adults Aged 20-89 Years/ D. Hou, Y. Song, Shanghai, China, p.A4884 P878 The Irish National Alpha-1 Antitrypsin Deficiency Targeted Detection Programme/ T.P. Carroll, L. Fee, S. Lee, E. Pentony, I. Ferrarotti, S. Ottaviani, N.G. McElvaney, Dublin, Ireland, p.A4885 Facilitator : S. Touray, MB BCh, MSc, Carlsbad, NM P879 Trendsand 30-Day Readmission Rate for Patients Discharged with COPD: Analysis of 1,680,843 Admissions/ A.S. Bath, V. Deepak, M. Farishta, Kalamazoo, MI, p.A4886 P880 COPD Due to Home Biomass Smoke Exposure in Rural Non-Smokers Brazilian Women/ M.S. Paschoalini, M.M. Cruz, Barreiras, Brazil, p.A4887 P881 The Resting Pulmonary Hyperinflation: A Determinant of the MMRC Dyspnea Scale in COPD Patients in a Real-Life Cohort?/ E.H. Ouaalaya, L. Falque, J.M. Dupis, M. Sabatini, C. Nocent-Ejnaini, A. Bernady, L. Nguyen, A. Ozier, F. Le Guillou, M. Molimard, C. Raherison-Semjen, Bordeaux, France, p.A4888 P882 Mild Chronic Obstructive Pulmonary Disease (COPD) and the Presence of Dyspnea: Inferences from the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Study/ M. Cherian, D. Jensen, S. Mursleen, E.C. Goodall, G. Nadeau, J. Bourbeau, Montreal, Canada, p.A4889 P883 Osteoporosis, Coronary Artery Calcification, and Chronic Obstructive Pulmonary Disease (COPD) in a Lung Cancer Screening Cohort/ K. Lowe, C. Thiele, E.L. Port, C. Wilson, S.M. Humphries, D.A. Lynch, H. Lindsey, J.D. Crapo, E.K. Silverman, J.H. Finigan, E.A. Regan, Denver, CO, p.A4890 P884 Metformin and Mortality from Chronic Lower Respiratory Disease/ E. Forno, A. Mendy, R. Gopal, J.F. Alcorn, Pittsburgh, PA, p.A4891 P885 Revised Blood Eosinophil Ranges in a Healthy General Population: Data from the LEAD Study/ A. Ofenheimer, S. Hartl, R. Breyer-Kohansal, M. Urban, M. Breyer, A. Schrott, M.J. Studnicka, O.C. Burghuber, Vienna, Austria, p.A4892 P886 Lung Cancer Survival Is Higher in Healthier States of the United States/ Y.C. Lee, R.A. Calderon Candelario, G.E. Holt, M.A. Campos, M. Mirsaeidi, Miami, FL, p.A4893 P887 Disparities in Access to Food and COPD-Related Outcomes/ E. Moughames, P. Galiatsatos, H. Woo, K. Romero-Rivero, S. Raju, E.A. Hoffman, V.E. Ortega, T. Parekh, J.A. Krishnan, M.B. Drummond, R.G. Buhr, A.P. Comellas, D. Couper, R. Paine, L.M. Paulin, N. Putcha, N.N. Hansel, Baltimore, MD, p.A4894 CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION C44 ASTHMA EPIDEMIOLOGY 9:15 a.m. - 4:15 p.m. KBHCCD Area D (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. ATS 2019 • Dallas, TX 256 TUESDAY • MAY 21